摘要
目的:研究 bcr-abl融合基因硫代磷酸反义寡核苷酸(Aspo)对 K562细胞生长特性的影响,探讨其在慢性粒细胞白血病(CML)基因治疗中的意义。方法:倒置显微镜下细胞活体观察;Aspo与细胞共同培养24h、48h、72h、96h及 120h,用0.4%台盼蓝染色计各处理组死活细胞数,甲基纤维素半固体培养法观察其克隆形成率的变化,流式细胞仪测定各处理组细胞P210蛋白表达变化。结果:Aspo处理后细胞仍呈克隆状生长,当 Aspo浓度达5μmol/L时,即可产生增殖抑制作用,呈一定的量效关系,其最大抑制效应时间为作用120h,当Aspo达10μmol/L时,在一定细胞浓度范围内(1×104/mL- 5× 105/mL),均有显著抑制作用,当Aspo浓度达5μmol/L以上时,K562细胞 P210蛋白表达明显下降甚至不表达。 b2a2型 Aspo对表达 b3a2型 mRNA的 K562细胞也表现出交叉抑制作用。结论:bcr-abl融合基因反义寡核苷酸对K562细胞具有特异性增殖抑制作用,在慢性粒细胞白血病基因治疗中值得深人研究。
AIM:To study the effect of bcr - abl gene antisense phosphorothioate oligonucleotides(Aspo) on K562 cell line and explore its significance in chronic myelogencous leukemia (CML) gene therapy. METHODS: Cells were exposed to oligomers, observed by inverted microscope. Cells inhibitory rate were determined by 0.4% trypan blue exclusion. CFU - K562 were cultured in 0.8% methylcellulose. P210 was measured by flow cytometry. RESULTS:K562 cells were treated with Aspo, they still grew in clone state and show antisense sequence specific and dose dependent. When the concentration of Aspo was more than 5μmol/L, the growth of cells was inhibited and P210 was down regulated or completely suppressed, and the greatest growth inhibition was at 120h. There was significant inhibition of cell proliferation in a rang of cells number from 1 × 10-4/mL to 5 × 10-4/mL after treatment with 10μmol/L Aspo. b2a2 Aspo was also effect on K562 cells which expressing b3a2 mRNA. CONCLUSION: bcr - abl Aspo has a specific growth inhibition effect on K562 cells, and worths further study in CML gene therapy.
出处
《中国病理生理杂志》
CAS
CSCD
北大核心
2000年第4期342-346,共5页
Chinese Journal of Pathophysiology